Pharma Co. Beats Investor Suit Over Licensing Agreement
A New York federal judge has dismissed a proposed investor class action against pharmaceutical company Molecular Partners, ruling the plaintiff failed to show the company misled investors about its progress in...To view the full article, register now.
Already a subscriber? Click here to view full article